Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy

被引：0
|
作者：
Michael Boyiadzis
Robert L. Redner
Anastasios Raptis
Jing-Zhou Hou
Mounzer Agha
Kenneth A. Foon
机构：
[1] University of Pittsburgh Cancer Institute,Division of Hematology
来源：
Annals of Hematology | 2011年 / 90卷
关键词：
Acute Myeloid Leukemia; Complete Remission; Etoposide; Anthracycline; Cytarabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 735
页数：2
相关论文
共 50 条
  • [1] Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy
    Boyiadzis, Michael
    Redner, Robert L.
    Raptis, Anastasios
    Hou, Jing-Zhou
    Agha, Mounzer
    Foon, Kenneth A.
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 733 - 735
  • [2] Etoposide and mitoxantrone in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy with cytarabine and idarubicin
    McHayleh, W. M.
    Redner, R.
    Sehgal, R.
    Raptis, A.
    Agha, M.
    Natale, J.
    Luong, T.
    Schlesselman, J. J.
    Foon, K.
    Boyiadzis, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin
    McHayleh, Wassim
    Sehgal, Rajesh
    Redner, Robert L.
    Raptis, Anastasios
    Agha, Mounzer
    Natale, James
    Luong, The Minh
    Schlesselman, James J.
    Foon, Kennteh A.
    Boyiadzis, Michael
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1848 - 1853
  • [4] Gemtuzumab ozogamicin in acute myeloid leukemia
    Godwin, C. D.
    Gale, R. P.
    Walter, R. B.
    LEUKEMIA, 2017, 31 (09) : 1855 - 1868
  • [5] Gemtuzumab ozogamicin for acute myeloid leukemia
    Appelbaum, Frederick R.
    Bernstein, Irwin D.
    BLOOD, 2017, 130 (22) : 2373 - 2376
  • [6] Gemtuzumab ozogamicin in acute myeloid leukemia
    C D Godwin
    R P Gale
    R B Walter
    Leukemia, 2017, 31 : 1855 - 1868
  • [7] Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia
    Gbadamosi, Mohammed
    Meshinchi, Soheil
    Lamba, Jatinder K.
    FUTURE ONCOLOGY, 2018, 14 (30) : 3199 - 3213
  • [8] Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
    Walter, Roland B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S95 - S96
  • [9] Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
    Giles, F
    Estey, E
    O'Brien, S
    CANCER, 2003, 98 (10) : 2095 - 2104
  • [10] Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia
    Baron, Jeffrey
    Wang, Eunice S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (06) : 549 - 559
12345